Specifically, elevated levels of phosphorylated Stat3 in tumor samples from 45 patients with high-risk breast cancer was correlated with an incomplete response to neo-adjuvant chemotherapy (i.e. poor prognostic feature) [20]. Here, STAT3 is linked to breast carcinoma.